HANNA NABIL 4
4 · BIOGEN IDEC INC · Filed Jan 9, 2004
Insider Transaction Report
Form 4
BIOGEN IDEC INCBIIB
HANNA NABIL
Chief Scientific OfficerOther
Transactions
- Exercise/Conversion
Common Stock
2004-01-08$0.50/sh+106,651$53,326→ 540,286 total - Exercise/Conversion
Incentive Stock Option (right to buy)
2004-01-08−106,651→ 102,068 totalExercise: $0.50From: 1995-03-16Exp: 2004-09-12→ Common Stock (106,651 underlying) - Sale
Common Stock
2004-01-08$41.00/sh−10,562$433,042→ 433,635 total - Exercise/Conversion
Incentive Stock Option (right to buy)
2004-01-08−10,562→ 226,506 totalExercise: $0.50From: 1995-03-16Exp: 2004-09-12→ Common Stock (10,562 underlying) - Exercise/Conversion
Common Stock
2004-01-08$0.50/sh+17,787$8,894→ 451,422 total - Exercise/Conversion
Incentive Stock Option (right to buy)
2004-01-08−17,787→ 208,719 totalExercise: $0.50From: 1995-03-16Exp: 2004-09-12→ Common Stock (17,787 underlying) - Exercise/Conversion
Common Stock
2004-01-08$0.50/sh+10,562$5,281→ 444,197 total - Sale
Common Stock
2004-01-08$41.00/sh−17,787$729,267→ 433,635 total - Sale
Common Stock
2004-01-08$41.00/sh−106,651$4,372,691→ 433,635 total
Footnotes (3)
- [F1]Represents sale by Nabil Hanna pursuant to a qualified written selling plan under SEC rule 10b5-1.
- [F2]Granted under Issuer's Employee Stock Option Plan, in an exempt transaction under SEC rule 16b-3(d).
- [F3]Option becomes exercisable as to 25% of the optioned shares on 9/13/95 and as to the balance of the shares in 36 equal monthly installments thereafter, subject to acceleration in the event the Issuer was to achieve a designated milestone.